研究について【2025年】

英文原著論文　Original papers

発刊済のものはabstractまたは本文にリンクしてあります。
Published papers are linked to PubMed



Kihara, H., Nakao, A., Konishi, T., Yamanouchi, J., Nishida, T., Nakamura, M., Takeuchi, S., Sato, Y., Akamatsu, Y., Tani, H., Wada, H., Tokui, E., Kawata, M., Kaimen, T., Ozaki, S., Iketani, C., Kawabe, K., Takada, K.

HIV-associated neurocognitive dysfunction in the Chugoku-Shikoku region of Japan: A cross-sectional study.

J Infect Chemother. 31(8): 102768, 2025 Jul



Yuya Masuda, Tatsuya Konishi, Yoshihiro Yakushijin, Shintaro Yamanaka, Shinji Hasebe, Jun Yamanouchi, Katsuto Takenaka.

Impact of body mass index on D-dimer diagnostic utility for deep vein thrombosis in patients with cancer: a single-center retrospective analysis.

Int J Clin Oncol. 2025 Aug;30(8):1545-1552.


Daisuke Hiraoka, Jun Ishizaki, Kenta Horie, Kensuke Oryoji, Shin-Ichi Mizuki, Katsuto Takenaka.

Relationship between HLA-DRB1 shared epitope alleles and peripheral blood monocyte counts in Japanese patients with rheumatoid arthritis.

PLoS One. 2025 Nov 5;20(11):e0336214.



Sugihara, T., Harigai, M., Uchida, HA., Yoshifuji, H., Maejima, Y., Ishizaki, J., Watanabe, Y., Dobashi, H., Komagata, Y., Tamura, N., Nakaoka, Y.; Japan Research Committee of the Ministry of Health, Labour, and Welfare for Intractable Vasculitis (JPVAS).

Performance of the modified 2022 ACR/EULAR giant cell arteritis classification criteria without age restriction for discriminating from Takayasu arteritis.

Arthritis Res Ther. 27(1): 19, 2025 Jan



Ri, M., Iida, S., Saito, K., Saito, Y., Maruyama, D., Asano, A., Fukuhara, S., Tsujimura, H., Miyazaki, K., Ota, S., Fukuhara, N., Negoro, E., Kuroda, J., Yoshida, S., Ohtsuka, E., Norifumi, T., Tabayashi, T., Takayama, N., Saito, T., Suzuki, Y., Harada, Y., Mizuno, I., Yoshida, I., Maruta, M., Takamatsu, Y., Katsuya, H., Yoshimitsu, M., Minami, Y., Kanato, K., Munakata, W., Nagai, H.

Lipidomic profiling of plasma from patients with multiple myeloma receiving bortezomib: an exploratory biomarker study of JCOG1105 (JCOG1105A1).

Cancer Chemother Pharmacol. 95(1): 29, 2025 Jan



Miyamae, T., Manabe, Y., Sugihara, T., Umezawa, N., Yoshifuji, H., Tamura, N., Abe, Y., Furuta, S., Nagafuchi, H., Ishizaki, J., Nakano, N., Atsumi, T., Karino, K., Amano, K., Kurasawa, T., Ito, S., Yoshimi, R., Ogawa, N., Banno, S., Naniwa, T., Ito, S., Hara, A., Hirahara, S., Uchida, HA., Onishi, Y., Murakawa, Y., Komagata, Y., Nakaoka, Y., Harigai, M.

Pregnancy and childbirth in Takayasu arteritis in Japan: A nationwide retrospective study.

Mod Rheumatol. 35(2): 339-344, 2025 Feb



Inoue, A., Miyazaki, Y., Watanabe, H., Nishikawa, M., Kusakabe, K., Ohnishi, T., Taniwaki, M., Honda, T., Kondo, T., Kinnami, S., Katayama, E., Shigekawa, S., Kurata, M., Kitazawa, R., Kunieda, T.

Reliable intraoperative diagnostic methods for PCNSL: utility of combining intraoperative immunohistochemistry, cytology, and flow cytometry in achieving optimal treatment.

Acta Neuro Belg. 125(1): 99-108, 2025 Feb



Sakatoku, K., Nakamae, H., Murata, M., Shimazu, Y., Takenaka, K., Kimura, F., Uchida, N., Nishida, T., Fukuda, T., Doki, N., Ishikawa, J., Sakaida, E., Kataoka, K., Shirane, S., Tanaka, M., Kobayashi, H., Sawa, M., Wakayama, T., Asada, N., Uehara, Y., Yoshimitsu, M., Kanda, J., Ohbiki, M., Atsuta, Y., Tachibana, T.

Improved transplant outcomes with alternative donors in myelofibrosis: a 20-year Japanese registry analysis of donor sources and the impact of ruxolitinib.

Am J Hematol. 100(7): 1259-1263, 2025 Jul



Makishima, H., Mikasa, T., Isogaya, K., Miyamoto, T., Yamauchi, T., Yokota, A., Onozawa, M., Ando, K., Ogawa, Y., Usuki, K., Yamauchi, T., Ota, S., Takada, S., Morita, Y., Ishikawa, T., Takenaka, K., Kuroda, J., Sekiguchi, N., Kawakita, T., Miyazaki, Y.

Association between gene mutations and outcomes in Japanese high-risk, AML patients: a phase 1/2 study of NS-87/CPX-351.

Int J Hematol. 122(1): 57-65, 2025 Jul



Akahoshi, Y., Nakasone, H., Takenaka, K., Ara, T., Tada, Y., Doki, N., Uchida, N., Tanaka, M., Hasegawa, Y., Takeda, W., Nishida, T., Ishikawa, J., Kurita, N., Sawa, M., Onizuka, M., Kako, S., Fujiwara, SI., Kataoka, K., Kawamura, K., Fukuda, T., Atsuta, Y., Yakushijin, K., Kanda, Y.

Heterogeneity of survival benefit conferred by letermovir.

Transplant Cell Ther. 31(7): 461e1-461.e12, 2025 Jul



Hashimoto, Y., Ito, T., Gotoh, A., Nakamae, M., Kimura, F., Koike, M., Kirito, K., Wada, H., Usuki, K., Tanaka, T., Mori, T., Wakita, S., Saito, TI., Kada, A., Saito, AM., Shimoda, K., Sugimoto, Y., Kurokawa, T., Tomita, A., Edahiro, Y., Kiyoi, H., Akashi, K., Matsumura, I., Takenaka, K., Komatsu, N.

Post-diagnosis hemorrhagic events are strongly associated with poor survival in patients with essential thrombocythemia.

EJHaem. 6(4): e70103, 2025 Jul



Kihara, H., Miyake, Y., Tanaka, K.

Relationship between number of older siblings and common cold among children aged 5 years: the Kyusyu Okinawa maternal and child health study.

Public Health Rep. 140(5-6): 592-597, 2025 Sep-Oct



Yamaguchi, H., Iino, M., Kowata, S., Yamamoto, R., Yamanouchi, J., Imamura, Y., Kirito, K., Yokoyama, K., Ito, T., Ishikawa, T., Shiratsuchi, M., Tomiyama, Y., Kamiya, H., Zhang, J., Jamieson, BD.

A phase 3 study of the efficacy and safety of avatrombopag in Japanese adults with chronic immune thrombocytopenia.

Int J Hematol. 122(4): 521-532, 2025 Oct



Ihara, Y., Kihara, H., Imoto, W., Okada, N., Kakeya, H., Kaneko, Y.

Impact of coronavirus disease on the incidence rate of methicillin-resistant Staphylococcus aureus among hospitalized patients with lung cancer: a nationwide retrospective cohort study in Japan.

J Pharm Health Care Sci. 11(1); 95, 2025 Oct



Mesa, R., Gill, H., Zhang, L., Jin, J., Kirito, K., Komatsu, N., Qin, A., Xiao, Z., Tashi, T., Shimoda, K., Ohishi, K., Chen, S., Zuo, X., Shirane, S., Hu, Y., Zhang, S., Wang, Y., Takenaka, K., Ichii, M., Xu, N., Shih, LY., Lim, KH., Lee, SE., Bae, SH., Teo, WZY, Maze, D., Oh, ST., Bose, P., Sato, T., Zagrijtschuk, O., Lin, S., Shih, WJ., Mascarenhas, J., Masarova, L.,; SURPASS-ET Study Group.

Ropeginterferon alfa-2b in hydroxyurea-intolerant or hydroxyurea-refractory essential thrombocythemia (SURPASS ET): a multicentre, open-label, randomised, active-controlled, phase 3 study.

Lancet Haematol. 12(11): e862-e875, 2025 Nov



Mengue M’efoue, S., Miyake, Y., Kihara, H., Tanaka, K.

Breastfeeding duration and risk of depressive symptoms in adolescents.

Pediatr Res. 98(5): 1726-1730, 2025 Nov



Zaimoku, Y., Yamazaki, H., Kanaya, M., Hiramoto, N., Ishiyama, K., Takenaka, K., Murata, M., Uchida, N., Doki, N., Yamamoto, R., Nishida, T., Onodera, K., Machida, S., Kanda, Y., Eto, T., Kataoka, K., Asada, N., Itagaki, M., Sakata-Yanagimoto, M., Ishimaru, F., Onizuka, M., Ichinohe, T., Atsuta, Y., Onishi, Y.

Loss-prone HLA class I alleles inform outcomes of early hematopoietic cell transplantation in acquired aplastic anemia.

Am J Hematol. 100(12): 2195-2208, 2025 Dec



Okada, Y., Sakatoku, K., Shirane, S., Murata, M., Takenaka, K., Hamano, Y., Doki, N., Kanda, Y., Uchida, N., Tanaka, M,. Nishida, T., Ishikawa, J., Asada, N., Hasegawa, Y., Machida, S., Mori, Y., Eto, T., Yoshimitsu, M., Fukuda, T., Atsuta, Y., Tachibana, T.

Risk stratification using dynamic international prognostic scoring system and splenomegaly in myelofibrosis treated with pretransplant JAK inhibitors.

Transplant Cell Ther. 31(12): 1008.e1-1008.e11, 2025 Dec



Saijo, M., Izumikawa, K., Suemori, K., Takahashi, T., Umekita, K., Ohge, H., Hatakenaka, M., Ikeda, K., Himeji, D., Yamanaka, A., Kadowaki, N., Kawamura, M., Kakihana, Y., Ito, T., Nosaka, K., Sakurai, T., Yoshikawa, T., Kurosu, T., Shimojima, M., Yasukawa, M.

Efficacy of favipiravir treatment for patients with severe fever with thrombocytopenia syndrome assessed with a historical control.

Antimicrob Agents Chemother. 69(12): e0106225, 2025 Dec